The stock of Nutex Health Inc (NUTX) has gone up by 0.66% for the week, with a -46.72% drop in the past month and a -64.29% drop in the past quarter. The volatility ratio for the week is 9.42%, and the volatility levels for the past 30 days are 16.00% for NUTX. The simple moving average for the past 20 days is -12.91% for NUTX’s stock, with a -78.44% simple moving average for the past 200 days.
Is It Worth Investing in Nutex Health Inc (NASDAQ: NUTX) Right Now?
The stock has a 36-month beta value of 0.02. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NUTX is 28.70M, and at present, short sellers hold a 0.62% of that float. On May 08, 2024, the average trading volume of NUTX was 277.43K shares.
NUTX) stock’s latest price update
Nutex Health Inc (NASDAQ: NUTX)’s stock price has dropped by -9.46 in relation to previous closing price of 0.67. Nevertheless, the company has seen a gain of 0.66% in its stock price over the last five trading days. PRNewsWire reported 2024-05-07 that HOUSTON, May 7, 2024 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the first quarter ended March 31, 2024 after the close of the stock market on Wednesday, May 8, 2024. The Company will discuss those results on a conference call on Friday, May 10, 2024 at 10:30am ET.
Analysts’ Opinion of NUTX
Many brokerage firms have already submitted their reports for NUTX stocks, with Northland Capital repeating the rating for NUTX by listing it as a “Outperform.” The predicted price for NUTX in the upcoming period, according to Northland Capital is $3 based on the research report published on February 22, 2023 of the previous year 2023.
NUTX Trading at -48.79% from the 50-Day Moving Average
After a stumble in the market that brought NUTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -93.41% of loss for the given period.
Volatility was left at 16.00%, however, over the last 30 days, the volatility rate increased by 9.42%, as shares sank -47.95% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -63.85% lower at present.
During the last 5 trading sessions, NUTX rose by +0.66%, which changed the moving average for the period of 200-days by -90.02% in comparison to the 20-day moving average, which settled at $0.6712. In addition, Nutex Health Inc saw -77.44% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NUTX starting from Vo Thomas T., who purchase 275,200 shares at the price of $0.23 back on Nov 20 ’23. After this action, Vo Thomas T. now owns 269,822,776 shares of Nutex Health Inc, valued at $62,195 using the latest closing price.
Vo Thomas T., the Chief Executive Officer of Nutex Health Inc, purchase 224,800 shares at $0.23 during a trade that took place back on Nov 17 ’23, which means that Vo Thomas T. is holding 269,547,576 shares at $51,704 based on the most recent closing price.
Stock Fundamentals for NUTX
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.14 for the gross margin
The net margin for Nutex Health Inc stands at -0.18. The total capital return value is set at -0.0. Equity return is now at value -58.21, with -11.03 for asset returns.
Based on Nutex Health Inc (NUTX), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.03. The debt to equity ratio resting at 0.75. The interest coverage ratio of the stock is -0.08.
Currently, EBITDA for the company is 16.3 million with net debt to EBITDA at 15.52. When we switch over and look at the enterprise to sales, we see a ratio of 1.15. The receivables turnover for the company is 3.94for trailing twelve months and the total asset turnover is 0.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.56.
Conclusion
To sum up, Nutex Health Inc (NUTX) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
